<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="164819">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01920997</url>
  </required_header>
  <id_info>
    <org_study_id>QE-2458-3</org_study_id>
    <nct_id>NCT01920997</nct_id>
  </id_info>
  <brief_title>Qing'E Formula Therapy on Menopausal Symptoms (Healthy Volunteers Recruitment for Control Study)</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shanghai University of Traditional Chinese Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Wuxi People’s Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Shanghai University of Traditional Chinese Medicine</source>
  <oversight_info>
    <authority>China: Ethics Committee</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will recruit 50 healthy women with normal menstrual cycles aged 40-50, to
      investigate the expression of their NEI network and urine metabolomics.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2013</start_date>
  <primary_completion_date type="Anticipated">October 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control</study_design>
  <primary_outcome>
    <measure>The expression of NEI network and Urine metabolomics</measure>
    <time_frame>2-5 days after menstruation</time_frame>
    <safety_issue>No</safety_issue>
    <description>The indices of NEI network include:
Hypothalamic-pituitary-adrenal axis: CRH, ATCH, CORT
Hypothalamic-pituitary-thyroid axis: TRH, T3, T4
Renin - angiotensin - aldosterone system: PRA, Ang2, ALD
Sex hormones: E2, FSH
Immune factors: TNF-α、IL-6、IL-1
Cardiovascular indicators: ET, NO, Hcy, Folic acid</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>No drug intervention</arm_group_label>
    <description>The objective of this study is to investigate the expression of NEI network and urine metabolomics of healthy women with normal menstrual cycles.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy women with normal menstrual cycles aged 40-50
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Healthy women with normal menstrual cycles aged 40-50.

          2. The score of Kupperman index is less than 15.

          3. Not alcoholics or smokers (past or smoking).

          4. Get subjects informed consent process should comply with GCP requirements.

        Exclusion Criteria:

          1. Volunteers with heart, liver, kidney disease or acute or chronic gastrointestinal
             diseases, or with diseases of blood, endocrine, neurological and other systems.

          2. Volunteers are participating in other clinical trials within 3 months.

          3. Volunteers who donated blood or loosed blood heavily within 3 months.

          4. Volunteers with previous history of mental illness, drug abuse or drug dependence.

          5. Volunteers who took drugs within 14 days before the trail.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Zheng Qingshan, PhD</last_name>
    <phone>+86-021-51322556</phone>
    <email>zheng.zqs@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Shanghai University of Traditional Chinese Medicine</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>210038</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yang Jie, MD</last_name>
      <phone>+86-0510-85350351</phone>
      <email>yangjie@wuxiph.com</email>
    </contact>
    <investigator>
      <last_name>He Qing, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>September 1, 2013</lastchanged_date>
  <firstreceived_date>August 8, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Healthy</keyword>
  <keyword>normal menstrual cycles</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
